TABLE 1.
MDR pumps inhibited by the EPIs used in this study
MDR pump(s) | Organism | Substrates | EPI(s) | Reference(s) |
---|---|---|---|---|
AcrAB | E. coli | Bile salts, fatty acids, antibiotics (tetracycline, chloramphenicol, quinolones, fluoroquinolones, rifampin), dyes, detergentsa | NMP, PAβN | 3, 7, 8, 21, 27, 31, 33 |
AcrEF | E. coli | Hydrophobic uncouplers, multiple structurally dissimilar antibiotics, basic dyes | NMP | 3, 33, 38 |
AcrAB | K. pneumoniae | Multiple structurally dissimilar antibiotics | PAβN | 4 |
MexAB, MexCD, MexEF | P. aeruginosa | Multiple structurally dissimilar antibiotics | NMP, PAβN | 1, 23, 39, 40 |
NorA | S. aureus | Tetracycline, chloramphenicol, quinolones, fluoroquinolones, reserpine, plant alkaloidsa | Thioridazineb | 30, 36 |
The quinolones include nalidixic acid, levofloxacin, and ciprofloxacin.
It should be noted that thioridazine has been shown to reduce vancomycin resistance in the gram-negative bacterium Enterococcus faecalis.